Current management of juvenile dermatomyositis in Germany and Austria: an online survey of pediatric rheumatologists and pediatric neurologists

Table 2 Choice of glucocorticoid regimen in moderate and severe juvenile dermatomyositis

Oral glucocorticoid therapy	Intravenous methylprednisolone pulse therapy
	Intermittent, ongoing		Once at onset of therapy		None
	Moderate JDM	Severe JDM	Moderate JDM	Severe JDM	Moderate JDM	Severe JDM
High-dose^a	5%	28%	6%	10%	10%	2%
Moderate-dose^b	19%	23%	19%	8%	0%	0%
Low-dose^c	19%	5%	3%	0%	0%	0%
None	16%	18%	1%	5%	0%	0%

^aprednisone equivalent of ≥1 mg/kg/day, ^bprednisone equivalent of > 0.2 to < 1 mg/kg/day, ^cprednisone equivalent ≤0.2 mg/kg/day
JDM juvenile dermatomyositis

ISSN: 1546-0096